AI stocks like Nvidia have outperformed the market. Click here to learn strategies to manage risk and enhance portfolio ...

Disease-free survival is significantly longer with adjuvant pembrolizumab than observation among patients with high-risk ...

For patients with limited-stage small cell lung cancer, adjuvant therapy with durvalumab leads to significantly longer ...

No Premier League manager departures so far this season; only 42 per cent of teams retain top-flight status after axing ...

Notably, patients benefited from pembrolizumab regardless of whether they achieved a pathologic complete response (pCR), ...

The following is a summary of “Impact of Donor−Recipient BMI Ratio on Survival Outcomes of Heart Transplant Recipients: A ...

The following is a summary of “Final, 10-Year outcomes with Nivolumab plus Ipilimumab in advanced melanoma,” published in the September 2024 issue of Dermatology by Wolchok et al. Researchers ...

Researchers developed a pan-immune-inflammation–based nomogram to accurately predict overall survival (OS) and ...

Patients with locally advanced cervical cancer were randomized to receive either pembrolizumab or placebo in combination with ...

Researchers conducted a single-center cohort study of more than 47,000 patients diagnosed with CRC from January 1, 1973, to ...

Discover the results from the phase 3 ENGOT-cx11/GOG-3047/KEYNOTE-A18 study, presented at ESMO 2024, Barcelona, Spain ...